Advanced search
Publication Cover
Patient Preference and Adherence Volume 5, 2011 - Issue
Submit an article Journal homepage
73
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence

Katarina Kelin1 Eli Lilly Australia Pty Ltd, West Ryde, NSW, AustraliaCorrespondence[email protected]
,
Timothy JR Lambert2 Discipline of Psychiatry, Brain and Mind Research Institute, The University of Sydney, Camperdown, NSW, Australia
,
Alan JM Brnabic3 Intercontinental Information Sciences, Eli Lilly Australia Pty Ltd, Macquarie Park, NSW, Australia
,
Richard Newton4 Peninsula Health Psychiatric Services, Frankston Hospital, Frankston, VIC, Australia (current affiliation: Department of Psychiatry, Austin Hospital, Heidelberg, VIC, Australia)
,
Wendy Ye3 Intercontinental Information Sciences, Eli Lilly Australia Pty Ltd, Macquarie Park, NSW, Australia
,
Raúl I Escamilla5 Schizophrenia Clinic, National Institute of Psychiatry, Mexico City, Mexico
,
Kuang-Peng Chen6 Department of Psychiatry, National Taiwan University Hospital, Yun-Lin, Taiwan
,
Liana Don7 Department of Psychiatry, University of Medicine Iuliu Hatieganu Cluj Napoca, Romania
,
William Montgomery1 Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia
,
Jamie Karagianis8 Lilly USA, Eli Lilly and Company, Indianapolis, IN, USA
&
Haya Ascher-Svanum9 Global Health Outcomes, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
 show all
Pages 213-222 | Published online: 09 May 2011

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Alex Kopelowicz, Ross A Baker, Cathy Zhao, Claudette Brewer, Erica Lawson & Timothy Peters-Strickland. (2017) A multicenter, open-label, pilot study evaluating the functionality of an integrated call center for a digital medicine system to optimize monitoring of adherence to oral aripiprazole in adult patients with serious mental illness. Neuropsychiatric Disease and Treatment 13, pages 2641-2651.
Read now
Gabriel Kaplan, Julio Casoy & Jacqueline Zummo. (2013) Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophrenia. Patient Preference and Adherence 7, pages 1171-1180.
Read now
Goran Medic, Kyoko Higashi, Kavi J Littlewood, Teresa Diez, Ola Granström & René S Kahn. (2013) Dosing frequency and adherence in chronic psychiatric disease: systematic review and meta-analysis. Neuropsychiatric Disease and Treatment 9, pages 119-131.
Read now
Haya Ascher-Svanum, Alan JM Brnabic, Anthony H Lawson, Bruce J Kinon, Virginia L Stauffer, Peter D Feldman & Katarina Kelin. (2012) Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia. Neuropsychiatric Disease and Treatment 8, pages 113-118.
Read now

Articles from other publishers (12)

Stefan Siebert, Karolina Leopold, Johanna Baumgardt, Laura-Sophie von Hardenberg, Eva Burkhardt & Andreas Bechdolf. (2022) Specialized inpatient treatment for young people with early psychosis: acute-treatment and 12-month results. European Archives of Psychiatry and Clinical Neuroscience 272:7, pages 1-14.
Crossref
Taishiro Kishimoto, Katsuhiko Hagi, Shunya Kurokawa, John M Kane & Christoph U Correll. (2021) Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies. The Lancet Psychiatry 8:5, pages 387-404.
Crossref
Ulrike Stentzel, Neeltje van den Berg, Lara N. Schulze, Thea Schwaneberg, Franziska Radicke, Jens M. Langosch, Harald J. Freyberger, Wolfgang Hoffmann & Hans-Jörgen Grabe. (2018) Predictors of medication adherence among patients with severe psychiatric disorders: findings from the baseline assessment of a randomized controlled trial (Tecla). BMC Psychiatry 18:1.
Crossref
Taishiro Kishimoto, Katsuhiko Hagi, Masahiro Nitta, Stefan Leucht, Mark Olfson, John M Kane & Christoph U Correll. (2018) Effectiveness of Long-Acting Injectable vs Oral Antipsychotics in Patients With Schizophrenia: A Meta-analysis of Prospective and Retrospective Cohort Studies. Schizophrenia Bulletin 44:3, pages 603-619.
Crossref
Ulrike Stentzel, Hans-Jörgen Grabe, Lara Strobel, Peter Penndorf, Jens Langosch, Harald J. Freyberger, Wolfgang Hoffmann & Neeltje van den Berg. (2015) Tecla: a telephone- and text-message based telemedical concept for patients with severe mental health disorders – study protocol for a controlled, randomized, study. BMC Psychiatry 15:1.
Crossref
Deena M. Ashoorian, Rowan M. Davidson, Daniel J.T. Rock, Milan Dragovic & Rhonda M. Clifford. (2015) Construction and validation of the My Medicines and Me Questionnaire for assessment of the self-reported side effects of psychotropic medication. International Clinical Psychopharmacology 30:4, pages 224-229.
Crossref
Simon Frey, Roland Linder, Georg Juckel & Tom Stargardt. (2013) Cost-effectiveness of long-acting injectable risperidone versus flupentixol decanoate in the treatment of schizophrenia: a Markov model parameterized using administrative data. The European Journal of Health Economics 15:2, pages 133-142.
Crossref
Steve Offord, Jay Lin, Bruce Wong, Dario Mirski & Ross A. Baker. (2013) Impact of Oral Antipsychotic Medication Adherence on Healthcare Resource Utilization Among Schizophrenia Patients with Medicare Coverage. Community Mental Health Journal 49:6, pages 625-629.
Crossref
István Bitter, Lajos Katona, János Zámbori, Péter Takács, László Fehér, Joris Diels, Miklós Bacskai, Zsolt Lang, Gergely Gyáni & Pál Czobor. (2013) Comparative effectiveness of depot and oral second generation antipsychotic drugs in schizophrenia: A nationwide study in Hungary. European Neuropsychopharmacology 23:11, pages 1383-1390.
Crossref
Jay Lin, Bruce Wong, Steve Offord & Dario Mirski. (2013) Healthcare Cost Reductions Associated with the Use of LAI Formulations of Antipsychotic Medications Versus Oral Among Patients with Schizophrenia. The Journal of Behavioral Health Services & Research 40:3, pages 355-366.
Crossref
Valentino Conti, Antonio Lora, Andrea Cipriani, Ida Fortino, Luca Merlino & Corrado Barbui. (2012) Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders. European Journal of Clinical Pharmacology 68:12, pages 1647-1655.
Crossref
Antonio Ciudad, Luis San, Miguel Bernardo, José M. Olivares, Pepa Polavieja, Amparo Valladares & Inmaculada Gilaberte. (2012) Relapse and therapeutic interventions in a 1-year observational cohort study of nonadherent outpatients with schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 36:2, pages 245-250.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.